Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4

Molecular Carcinogenesis

Volumn 33, Issue 2, 2002, Pages 105-112

  Angel, Joe M ^a   Richie, Ellen R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemical carcinogenesis; Complex genetic traits; Tumor susceptibility genes

Indexed keywords

METHYLNITROSOUREA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 4; CHROMOSOME 7; CONTROLLED STUDY; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC CROSS; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; HOMOZYGOSITY; INBRED STRAIN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS LYMPHOMA;

ANIMALS; CARCINOGENS; CHROMOSOME MAPPING; LYMPHOMA; METHYLNITROSOUREA; MICE; MICE, INBRED C57BL; THYMUS NEOPLASMS;

EID: 0036151970     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10026     Document Type: Article

References (94)

1. Human cancer syndromes: Clues to the origin and nature of cancer
2. Molecular epidemiology: Insights into cancer susceptibility risk assessment and prevention
3. Inherited predisposition to cancer
4. Cell cycle control and cancer
5. Genetic susceptibility to cancer
6. Localization of a novel chromosome 7 locus that suppresses development of N-methyl-N-nitrosourea-induced murine thymic lymphomas
7. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
8. A locus that influences susceptibility to 12-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3
9. Genetic identification of Mom-1: A major modifier locus affecting Mininduced intestinal neoplasia in the mouse
10. At least four genes and sex are associated with susceptibility to urethaneinduced pulmonary adenomas in mice
11. A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp703 and G7 within the H2 complex
12. Complex interactions of new quantitative trait loci Slucl Sluc2 Sluc3 Sluc4 that influence the susceptibility to lung cancer in the mouse
13. Chromosome mapping of murine susceptibility loci to liver carcinogenesis
14. Genetic identification of Mcs-1 a rat mammary carcinoma suppressor gene
15. Genetic analysis of colon cancer susceptibility in mice
16. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ
17. Identification of hepatocarcinogen-resistance genes in DBA/2 mice
18. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice
19. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression
20. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis
21. Multigenic control of skin tumor susceptibility in SENCARA/Pt mice
22. Scc-1, a novel colon cancer susceptibility gene in the mouse: Linkage to CD44 (Ly-24 Pgp-1) on chromosome 2
23. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse different from the genes known to be somatically mutated in colon cancer
24. Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice
25. Distinct genetic loci control development of benign and malignant skin tumours in mice
26. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice
27. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice
28. Tlagl, a novel murine tumor susceptibility gene that regulates MNU-induced thymic lymphoma development
29. Genetic identification of multiple loci that control breast cancer susceptibility in the rat
30. Genetically determined susceptibility of Fischer 344 rats to propylnitrosourea-induced thymic lymphomas
31. Genetic interaction and single gene effects in colon tumour susceptibility in mice
32. Tli1 a resistance locus for carcinogen-induced T-lymphoma
33. T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models
34. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10
35. Effects of dose and schedule of methyl-nitrosourea on incidence of malignant lymphoma in adult female mice
36. Thymomas induced by simple alkylating agents in C57BI/Cbi mice: Kinetics of the dose response
37. Methylnitrosourea induction of thymomas in AKR mice requires one or two hits only
38. Genetics of N-methyl-N-nitrosourea induction of thymic lymphomas in AKLR/J mice: Assignment of a susceptibility gene to mouse chromosome 7
39. Induction of thymomas by N-methyl-N-nitrosourea in AKR mice: Interaction between the chemical carcinogen and endogenous murine leukaemia viruses
40. A new class of murine leukemia virus associated with development of spontaneous lymphomas
41. Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas
42. Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice
43. Proviral structure and differentiation antigen phenotype of spontaneous and chemically induced AKR lymphomas
44. N-methyl-N-nitrosourea-induced T-lymphomas of AKR/J mice contain somatically acquired ecotropic-like murine leukemia proviruses
45. Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice
46. Influence of sex and carcinogen treatment protocol on tumor latency and frequency of K-ras mutations in N-methyl-N-nitrosourea-induced lymphomas
47. A genetic map of the mouse suitable for typing intraspecific crosses
48. Genetic identification of endogenous polytropic proviruses by using recombinant inbred mice
49. A linkage map of endogenous murine leukemia proviruses
50. Genetic dissection of complex traits: Guidelines for interpreting and reporting results
51. Genotypic selection provides experimental confirmation for an alcohol consumption quantitative trait locus in mouse
52. Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c x AKR cross: A genetic analysis
53. FV-1 regulation of lymphoma development and of thymic, ecotropic and xenotropic MuLV expression in mice of the AKR/J × RF/J Cross
54. Restriction of murine leukemia viruses by FV-1: A model for studying host genetic control of retroviral gene movement and leukemogenesis
55. Susceptibility of AKXD recombinant inbred mouse strains to lymphomas
56. Genetic and epigenetic resistance of SL/Ni mice to lymphomas
57. Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice
58. Genetics of susceptibility to radiation-induced leukemia: Mapping of genes involved to chromosomes 1, 2, and 4, and implicatons for a viral etiology in the disease
59. Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice
60. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas
61. A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4
62. Specificity of loss of heterozygosity in radiation-induced mouse myeloid and lymphoid leukaemias
63. Allelic loss and promoter hypermethylation of the p15INK4b gene features in mouse radiation-induced lymphoid-but not myeloid-leukaemias
64. Frequent loss of heterozygosity on chromosomes 4, 12, and 10 in radiation-induced lymphomas in mice
65. Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas
66. Allelotype analysis of 2′3′-dideoxycytidine-and 1,3-butadiene-induced lymphomas in B6C3F1 mice
67. INK4b genes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas
68. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4
69. Efficiency alleles of the Pctrl modifier locus for plasmacytoma susceptibility
70. Inactivation of the cyclin-dependent kinase inhibitor p151NK4b by deletion and de novo methylation with independence of p16INK41 alterations in murine primary T-cell lymphomas
71. Hypermethylation of the cell cycle inhibitor p15INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas
72. Candidate tumor-suppressor genes MTS1 (p161NK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias
73. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias
74. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/ MTS2 in human leukemias and lymphomas
75. ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1
76. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells
77. Clinical relevance of Fit1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL)
78. Thymic tumorigenesis induced by overexpression of p561ck
79. Frequent activation of the Ick gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas
80. Expression of TAL-1 proteins in human tissues
81. Differential expression of the LYL, SCI, and E2A helix-loop-helix genes within the hemopoietic system
82. The myc gene family proteins and their role in transformation and differentiation
83. Jun, the oncoprotein
84. TAL1, TAL2 and LYLI: A family of basic helix-loop-helix proteins implicated in T cell acute leukaemia
85. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity
86. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphobastic leukemia
87. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia
88. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice
89. Protein dimerization between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice
90. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice
91. SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-Ta chain expression